What is Artiva Biotherapeutics, Inc.'s free cash flow yield?

Artiva Biotherapeutics, Inc. (ARTV) reported free cash flow yield of -50.4% in Q1 2026.

How has Artiva Biotherapeutics, Inc.'s free cash flow yield changed year-over-year?

Artiva Biotherapeutics, Inc.'s free cash flow yield increased by 39.6% year-over-year, from -83.4% to -50.4%.

What does free cash flow yield mean?

Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.

Artiva Biotherapeutics, Inc. ARTV Free cash flow yield

Free cash flow yield at other companies

Bristol-Myers SquibbBMY

9.6%-0.9pp

Gilead SciencesGILD

5.9%-1.1pp

Kyverna Therapeutics, Inc.KYTX

-27.4%-10.5pp

Allogene TherapeuticsALLO

-18.4%-7.6pp

Immix Biopharma, Inc.IMMX

-6.8%-2.9pp

ImmunityBio, Inc.IBRX

-3.8%-1.6pp

Other financials

Income statement

See full

Revenue-—

Operating income-$24.4M-10.2%

Net income-$23.5M-15.8%

EPS (diluted)-$0.95-14.5%

Balance sheet

See full

Cash & equivalents$21.4M-30.6%

Total debt$10.3M-26.7%

Total equity$87.8M-48.0%

Total assets$106.0M-44.6%

Cash flow

See full

Operating cash flow-$21.0M-5.6%

CapEx$242.0K-52.6%

Free cash flow-$21.2M-4.1%

Valuation

See full

Market cap$429.03M+1,015%

Enterprise value$417.88M+1,832%

Profitability

See full

Operating margin-83.9%—

Net margin-79.3%—

Returns & leverage

See full

Return on equity-67.9%—

Debt / equity0.1×0.0×

Current ratio8.2×-5.8×

Where this comes from

Calculated from Artiva Biotherapeutics, Inc.’s reported figures.

free cash flow/market cap=-50.4%

Based on trailing twelve months.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s free cash flow yield?: Artiva Biotherapeutics, Inc. (ARTV) reported free cash flow yield of -50.4% in Q1 2026.
How has Artiva Biotherapeutics, Inc.'s free cash flow yield changed year-over-year?: Artiva Biotherapeutics, Inc.'s free cash flow yield increased by 39.6% year-over-year, from -83.4% to -50.4%.
What does free cash flow yield mean?: Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.